Current immunoPET advancements in HNSCC research have leveraged the nuclear properties of radionuclides such as 89Zr and 64Cu conjugated to EGFR-targeting mAbs to obtain high-resolution images of tracer uptake in HNSCC patients. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.